Check-Cap Ltd (CHEK), an Israeli clinical medical diagnostics company, saw its stock price surge 233.8% during Monday's pre-market trading session following the announcement of a merger agreement with MBody AI. Under the terms of the agreement, MBody AI will hold 90% of the combined entity's shares, while Check-Cap will retain a 10% stake. Both companies aim to enter the high-growth artificial intelligence sector through this strategic combination.